Aga Khan University
aku.eduTotal trials
317
Active
41
Phase 3
30
Total enrollment
5,763,509
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 18 of 18 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Acotiamide | — | — | — | — | — | 1 | |
| itopride | — | — | — | — | — | 1 | |
| Enhanced Recovery After Surgery | — | — | — | — | — | 1 | |
| Control | — | — | — | — | — | 1 | |
| Methylprednisolone | — | — | — | — | — | 1 | |
| Saline | — | — | — | — | 2 | ||
| MMS Plus | — | — | — | — | — | 1 | |
| sodium acetate group will receive sodium acetate in the neonatal PN. | — | — | — | — | — | 1 | |
| sodium chloride group will receive sodium chloride in the neonatal PN. | — | — | — | — | — | 1 | |
| Vitamin D | — | — | — | — | 2 | ||
| Oral Vancomycin | — | — | — | — | — | 1 | |
| VE818 | — | — | — | — | — | 1 | |
| Ketamine | — | — | — | — | — | 1 | |
| Nalbuphine | — | — | — | — | — | 1 | |
| Paracetamol | — | — | — | — | — | 1 | |
| LMW Heparin 5000 U/ML-Aspirin 75 MG | — | — | — | — | — | 1 | |
| LMW Heparin 5000 U/ML | — | — | — | — | — | 1 | |
| Benazir Nashonuma Program | — | — | — | — | — | 1 |
Next readouts
- 2025-04-30
- 2025-05-10
- 2025-06-30
- 2025-12
- 2025-12-20
- 2026-06-30
- 2026-08-01
- 2026-08-31
- 2026-12
- 2026-12-01
Top conditions
- Anemia10
- Hypertension10
- Malnutrition9
- Stunting9
- Pregnancy7
- Breast Cancer6
- Pneumonia5
- Polio5
Frequently asked questions about Aga Khan University
- How many clinical trials does Aga Khan University have on ClinicalTrials.gov?
- Aga Khan University is listed as the lead sponsor on 317 clinical trials in ClinicalTrials.gov, 41 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Aga Khan University's trials are in Phase 3?
- 30 of Aga Khan University's trials are in Phase 3, spread across 18 active drug programs.
- What therapeutic areas does Aga Khan University focus on?
- Aga Khan University's most-studied conditions on ClinicalTrials.gov are Anemia, Hypertension, Malnutrition, Stunting, Pregnancy.
- When are Aga Khan University's next clinical trial readouts?
- Aga Khan University has 10 upcoming primary-completion readouts tracked here; the soonest is “Effect of Methylprednisolone on Systemic Inflammatory Response During Pediatric Congenital Open-Heart Surgery”, expected around 2025-04-30.